🔗 Share this article

An underground market for unapproved weight-loss drugs is propelled by TikTok fitness influencers and vendors on messaging platforms, according to recent findings.

Experimental Treatment Gaining Traction Online

The experimental drug, which remains in clinical trials, is being promoted by online personalities for its supposed fat-burning effects. Followers are encouraged to message these accounts directly for source information, while also obtaining promotional offers.

Thriving Commerce on Social Networks

Separately, a robust trade exists on Telegram, where communities with thousands of members share comparison images, injection guides and assertions of rapid British shipping. Sellers promote the drug there before redirecting customers to other platforms for transactions.

Learning About Retatrutide

This medication is an experimental injection created by US drugmaker Eli Lilly. The drug targets three intestinal hormones – GLP-1, GIP and glucagon. Preliminary studies suggest it could help individuals lose up to a quarter of their body weight. Referred to as the “triple G”, the drug is being promoted digitally as the successor to Ozempic.

Medical Professionals Voice Concerns

However, physicians and pharmacists have warned that the sale of what is still an unapproved drug in the United Kingdom is a cause for concern and could lead to users administering substances of unknown origin.

Some professionals stated the demand for retatrutide could be linked to the rising cost of approved slimming products such as Mounjaro.

Legal Position and Enforcement

Selling the unapproved drug on social media or messaging apps is prohibited in the UK, as it is an unlicensed drug that must not be promoted or distributed for human use under the Human Medicines Regulations 2012.

Several influencers try to sidestep the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but advertising and distribution can still breach pharmaceutical, advertising, and customer regulations, potentially leading to fines, legal action or prison.

Platform Reaction and Content Removal

Based on TikTok, the platform has taken down violative material and prohibited related hashtags and query recommendations. The organization stated it was dedicated to maintaining the platform secure and investing in enhancing enforcement strategies.

Online Marketplace Operations

Research also discovered communities with up to 9,000 members marketing the experimental drug using Telegram's built-in search feature, which operates like a online catalog. Entering “retatrutide” instantly brings up groups with thousands of users, populated with photos of slimming results, positive testimonials and detailed instructions for mixing or administering at residence.

After moments of entering one community, a vendor posted contact information, where the majority of purchases occur. The vendor sent an guidebook and guaranteed delivery within two days. When asked whether the substance was genuine, one vendor responded: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. None inquired about weight, medical conditions or past usage.

Product Information and Pricing

Inside these communities, messages display black plastic packages with postal service labels, stating to contain new batches. One communication stated: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, mixed at home with sterile water, or pre-filled injectors typically sold at 160 pounds for 20mg. When asked how long a injector should be used, sellers give conflicting answers varying between a several days to “depends on your body”.

Platform Moderation and Safety Actions

A representative for the messaging service said it regularly moderated harmful content on its platform including material that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“People are administering materials they cannot confirm. Even if the science behind this drug is sound, these digital products may not include what they advertise,” said a pharmacy expert, the director of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of an online medical service linked the increase in demand to current cost increases for authorized weight-loss medications such as Mounjaro. “With costs increasing, individuals are turning to online platforms. But counterfeit injections are extremely risky. You cannot know what’s contained or whether the environment they were made in was clean,” she said.

Her staff has previously seen individuals injured by personal administration from unverified suppliers. “We recognize the disappointment, but buying from Telegram or communication platforms is gambling with your health,” stated the doctor. “These substances could be impure or incorrectly dosed.”

Producer Position

A representative from Eli Lilly said the substance was in phase 3 clinical trials and had not been evaluated or authorized by any regulatory agency globally. “Therefore at this point no one can sell [it] for human use,” they explained, noting that any item “misleadingly claiming itself as a company investigational substance not yet approved … may subject users to potentially serious health risks”.